The effect of Oncotype DX ® on adjuvant chemotherapy treatment decisions in early breast cancer
The effect of Oncotype DX ® on adjuvant chemotherapy treatment decisions in early breast cancer
About this item
Full title
Author / Creator
Rabie, MA , Rankin, A , Burger, A and Youssef, MMG
Publisher
England: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
The aim of this study was to objectively establish the value of the Oncotype DX
(ODX) gene assay in adjuvant treatment decisions for intermediate risk patients with early, oestrogen receptor positive, human epidermal growth factor receptor 2 negative, lymph node negative breast cancer at a district general hospital.
All patients who underwent...
Alternative Titles
Full title
The effect of Oncotype DX ® on adjuvant chemotherapy treatment decisions in early breast cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6818070
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6818070
Other Identifiers
ISSN
0035-8843
E-ISSN
1478-7083
DOI
10.1308/rcsann.2019.0096
